Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine
about
Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications.Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments.Vasoactive peptides in cardiovascular (patho)physiology.Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?Almotriptan: meeting today's needs in acute migraine treatment.Almotriptan in the treatment of migraine.Almotriptan for the acute treatment of adolescent migraine.Almotriptan: a review of 10 years' clinical experience.Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).Oral sumatriptan and almotriptan--delimiting the MAOI effect.Triptans in the treatment of migraine: drug selection by means of the SOJA method.Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A.Metabolism-guided drug design
P2860
Q33671813-12DBA386-D22B-4285-89C8-61F6582D5158Q35015993-4E7A89D1-C7D2-4031-8EC5-9D8C4D187928Q35646205-06A0732A-68A3-489C-A7CD-65C5697D30E8Q36662888-14F68EE2-14CA-4614-B61B-6CCA6F2BC91FQ36815987-1D2D580A-3184-43BD-98F4-99EEB318F276Q36941961-F706D54A-DC00-4866-A826-15F90C23DE83Q37021307-F9C4A795-EA14-4DFA-B79F-B016388B627DQ37129812-B2980654-3924-4506-BE21-A0F185D0636AQ37786624-9A70E635-10DE-4F14-810B-A6710FA8E2D7Q37800072-A3DBA0A0-DB05-4986-AAE8-B492FBD6F897Q38255420-197ADBE7-CC24-4440-99FC-E043570674B3Q46045347-4DCFC88C-2579-462A-ABFF-0FA396D48C92Q46955158-373108E5-4B88-4FCA-BCDF-0FEA311E0D20Q52334679-13E1B9FE-B1D2-4179-BE3B-FE2DF00F560EQ56115898-21BDFC46-9F26-45EF-BCDD-F571D8FB37FA
P2860
Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Clinical pharmacokinetics of a ...... for the treatment of migraine
@ast
Clinical pharmacokinetics of a ...... for the treatment of migraine
@en
Clinical pharmacokinetics of a ...... for the treatment of migraine
@nl
type
label
Clinical pharmacokinetics of a ...... for the treatment of migraine
@ast
Clinical pharmacokinetics of a ...... for the treatment of migraine
@en
Clinical pharmacokinetics of a ...... for the treatment of migraine
@nl
prefLabel
Clinical pharmacokinetics of a ...... for the treatment of migraine
@ast
Clinical pharmacokinetics of a ...... for the treatment of migraine
@en
Clinical pharmacokinetics of a ...... for the treatment of migraine
@nl
P921
P1476
Clinical pharmacokinetics of a ...... for the treatment of migraine
@en
P2093
Janet D McEnroe
Joseph C Fleishaker
P304
P356
10.2165/00003088-200544030-00002
P407
P577
2005-01-01T00:00:00Z
P6179
1033528744